The $100 price premium for 503B products reflects additional quality-control testing
Clinical trials show an average of 1517% body weight reduction over 68 weeks
Looking forward, Gan & Lee is committed to achieving comprehensive coverage across the diabetes treatment landscape and further enhancing its competitive position in this therapeutic area
In the cardiovascular system, atherosclerosis becomes apparent as the invisible killer. Atherosclerosis causes cerebral ischemia, or angina pectoris, with the development of atherosclerotic plaques
Commonly prescribed medications from this drug class (GLP-1 receptor agonists) include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)